Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 USD | +3.49% | -2.42% | +81.75% |
05-03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
05-02 | Geron Shares Decline After Q1 Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.75% | 2.21B | |
+10.00% | 106B | |
+0.65% | 104B | |
+6.72% | 23.25B | |
-13.64% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.79% | 16.99B | |
+8.89% | 14.26B | |
+44.47% | 12.76B |
- Stock Market
- Equities
- GERN Stock
- News Geron Corporation
- Geron Says First Patient Dosed in Early Trial of Imetelstat to Treat Bone Marrow Cancer